Ligand Reports First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ligand Reports First Quarter 2020 Financial Results

Ligand Pharma (LGND) Tops Q1 EPS by 23c; Raises Outlook

May 6, 2020 4:04 PM EDT

Ligand Pharma (NASDAQ: LGND) reported Q1 EPS of $0.89, $0.23 better than the analyst estimate of $0.66. Revenue for the quarter came in at $33.2 million versus the consensus estimate of $26.53 million.

Our first quarter financial results feature strong sales of Captisol to partners evaluating remdesivir in multiple... More